Third Patient Monitoring Roundtable 2023 - Telemedicine in focus

The third roundtable of the year was something special: On the occasion of the opening day of the DMEA on 25 April, together with the Healthcare Experience Meetup of IBM iX Berlin, we addressed the question "Telemedicine - panacea or means to an end?

The IBM Health Industry Lab was packed with people with expertise in digital health and monitoring technologies. The event was centred around a panel discussion, followed by a Q&A session and networking opportunities. 

The panel discussed the individual definition of the term "telemedicine", in which use cases its application makes sense (and when the technology reaches its limits) and to what extent telemedicine will play a role in the care of the future. The panelists were:

  • Dr. med. Björn Weiß, Deputy Head of the Department of Anaesthesiology and Intensive Care Medicine at Charité - Universitätsmedizin Berlin

  • Sebastian Vorberg, CEO of QuR digital and Spokesman of the Board of Bundesverband Internetmedizin (BiM)

  • Verena Mauckisch, Nurse with a specialisation in heart failure and study assistant in cardiovascular telemedicine at the DHZC

  • Thorsten Frenzel, Head of Business Operations of Medgate Germany

NOTE: The next roundtable will take place on 30 May on the topic of "Monitoring in the hospital of the future - what options are currently available in general wards?“. Further information and the possibility to register can be found here.

We would like to thank all participants for an extremely interesting and at the same time entertaining event, as always! We would especially like to express our gratitude to the IBM iX team for hosting us.

The Patient Monitoring Roundtable is organised by the Institute for Medical Informatics of the Charité - Universitätsmedizin Berlin in cooperation with INCH e.V. (Initiative for Collaboration and Innovation in Healthcare e.V.) and Hacking Health Berlin.

Previous
Previous

Roundtable No°4 | 2023: Monitoring in the hospital of the future

Next
Next

Roundtable No. 2 in 2023: Continuous Glucose Monitoring